Have a personal or library account? Click to login
Prevalence of Risk Factors Among Women With Osteoporosis Cover
Open Access
|Oct 2017

References

  1. 1. Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consens Statement 2000, 27-29; 17(1): 1-36.
  2. 2. WHO (2003). Prevention and Management of Osteoporosis. WHO Technical Report Series 919. Geneva:World Health Organization
  3. 3. Johnell O, Kanis JA. (2006). An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis Int. 17(12), 1726-33. DOI: 10.1007/s00198-006-0172-4.10.1007/s00198-006-0172-416983459
  4. 4. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. (1994). The diagnosis of osteoporosis. J Bone Miner Res. 9(8), 1137-41. DOI: 10.1002/ jbmr.5650090802.10.1002/jbmr.56500908027976495
  5. 5. IOF One-Minute Osteoporosis Risk Test. Aveliable at: https://www.iofbonehealth.org/sites/default/files/PDFs/2012-IOF_risk_test-english%5BWEB%5D_0.pdf
  6. 6. Krall EA, Dawson-Hughes B. (1993). Heritable and life-style determinants of bone mineral density. J Bone and Mineral Research. 8 (1), 1-9. DOI: 10.1002/ jbmr.5650080102.10.1002/jbmr.56500801028427042
  7. 7. Gueguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G. (1995). Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res. 10, 2017-2022. DOI: 10.1002/jbmr.5650101223.321
  8. 8. Hans D, Durosier C, Kanis JA, Johansson H, Schott- Pethelaz AM, Krieg MA. (2008). Assessment of the 10-year probability of osteoporotic hip fracture combining clinical risk factors and heel bone ultrasound: the EPISEM prospective cohort of 12,958 elderly women. J Bone Miner Res. 23(7), 1045-51. DOI: 10.1359/jbmr.080229.10.1359/jbmr.08022918302507
  9. 9. Asomaning K, Bertone-Johnson ER, Nasca PC, Hooven F, Pekow PS. (2006). The association between body mass index and osteoporosis in patients referred for a bone mineral density examination. J Womens Health (Larchmt). 15(9), 1028-34. DOI: 10.1089/jwh.2006.15.1028.10.1089/jwh.2006.15.102817125421
  10. 10. Fawzy T, Muttappallymyalil J, Sreedharan J, Ahmed A, Alshamsi SO, Al Ali MS, Al Balsooshi KA. (2011). Association between Body Mass Index and Bone Mineral Density in Patients Referred for Dual-Energy X-Ray Absorptiometry Scan in Ajman, UAE. J Osteoporos. 2011,876309. DOI: 10.4061/2011/876309.10.4061/2011/876309313527721772978
  11. 11. Gallagher JC, Riggs BL, DeLuca HF. (1980). Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab. 51(6),1359-1364.10.1210/jcem-51-6-13596255005
  12. 12. Siiteri PK. (1987). Adipose tissue as a source of hormones. Am J Clin Nutr. 45(1 Suppl), 277-282.
  13. 13. Migliaccio S, Greco EA, Fornari R, Donini LM, Lenzi A. (2011). Is obesity in women protective against osteoporosis? Diabetes Metab Syndr Obes. 4, 273-282.
  14. 14. Grujić V, Dragnić N, Radić I, Harhaji S, Susnjević S. (2010). Overweight and obesity among adults in Serbia: results from the National Health Survey. Eat Weight Disord. 15(1-2), 34-42.10.1007/BF0332527820571319
  15. 15. Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH. (2014). Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford). 53(10), 1759-66. DOI: 10.1093/rheumatology/keu162.10.1093/rheumatology/keu16224764264
  16. 16. WHO Report on the Global Tobacco Epidemic, 2015. Available at: http://www.who.int/tobacco/surveillance/policy/country_profile/srb.pdf.
  17. 17. Schmitt NM, Schmitt J, Doren M. (2009). The role of physical activity in the prevention of osteoporosis in postmenopausal women-An update. Maturitas. 20;63(1), 34-38. DOI: 10.1016/j.maturitas.2009.03.002.10.1016/j.maturitas.2009.03.00219356867
  18. 18. Borer KT. (2005). Physical activity in the prevention and amelioration of osteoporosis in women : interaction of mechanical, hormonal and dietary factors. Sports Med. 35(9), 779-830.10.2165/00007256-200535090-0000416138787
  19. 19. WHO Scientific Group on the Prevention and Management of Osteoporosis (2000 : Geneva, Switzerland) (2003).
  20. 20. Picado C, Luengo M. (1996). Corticosteroid-induced bone loss. Prevention and management. Drug Saf. 15(5), 347-59.10.2165/00002018-199615050-000058941496
  21. 21. Dhanwal DK. (2011). Thyroid disorders and bone mineral metabolism. Indian J Endocrinol Metab. 15(2), 107-12. DOI: 10.4103/2230-8210.8333910.4103/2230-8210.83339316986921966645
  22. 22. Vanderpump MP. (2011). The epidemiology of thyroid disease. Br Med Bull. 99, 39-51. DOI: 10.1093/bmb/ldr03010.1093/bmb/ldr03021893493
  23. 23. Adami S, Marcocci C, Gatti D. (2002). Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res. 17(2), 18-23.
  24. 24. Sunyecz JA. (2008). The use of calcium and vitamin D in the management of osteoporosis. Ther Clin Risk Manag. 4(4), 827-36.
DOI: https://doi.org/10.1515/sjecr-2016-0080 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 239 - 243
Submitted on: Jul 19, 2016
|
Accepted on: Oct 5, 2016
|
Published on: Oct 19, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Dalibor Stajic, Sandra Zivanovic, Ana Miric, Marija Sekulic, Nela Djonovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.